Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: Intestinal ischemia/reperfusion (I/R) injury commonly occurs during perioperative periods, resulting in high morbidity and mortality on a global scale. Dexmedetomidine (Dex) is a selective α2-agonist that is frequently applied during perioperative periods for its analgesia effect; however, its ability to provide protection against intestinal I/R injury and underlying molecular mechanisms remain unclear. Methods: To fill this gap, the protection of Dex against I/R injury was examined in a rat model of intestinal I/R injury and in an inflammation cell model, which was induced by tumor necrosis factor-alpha (TNF-α) plus interferon-gamma (IFN-γ) stimulation. Results: Our data demonstrated that Dex had protective effects against intestinal I/R injury in rats. Dex was also found to promote mitophagy and inhibit apoptosis of enteric glial cells (EGCs) in the inflammation cell model. PINK1 downregulated p53 expression by promoting the phosphorylation of HDAC3. Further studies revealed that Dex provided protection against experimentally induced intestinal I/R injury in rats, while enhancing mitophagy, and suppressing apoptosis of EGCs through SIRT3-mediated PINK1/HDAC3/p53 pathway in the inflammation cell model. Conclusion: Hence, these findings provide evidence supporting the protective effect of Dex against intestinal I/R injury and its underlying mechanism involving the SIRT3/PINK1/HDAC3/p53 axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dexmedetomidine, beyond its sedative effects via α2 receptors, activates the neuronal mitochondrial deacetylase Sirt3, improving oxidative phosphorylation and reducing reactive oxygen species (ROS) production [10,11].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Zhou, H., Wang, J., Zhu, P., Zhu, H., Toan, S., Hu, S., Ren, J., & Chen, Y. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0682-1 · Cited by 297
RetractedDas, S., Mitrovsky, G., Vasanthi, H. R., & Das, D. K. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/345105 · Cited by 173
RetractedVenkatesan, V., Madhira, S. L., Malakapalli, V., Chalasani, M., Shaik, S. N., Seshadri, V., Kodavalla, V., Bhonde, R. R., & Nappanveettil, G. (2013) · BioMed Research International · doi:10.1155/2013/617569 · Cited by 20
RetractedChiu, C.-J. (1970) · Archives of Surgery · doi:10.1001/archsurg.1970.01340280030009 · Cited by 1,800
LC3 conjugation system in mammalian autophagy
Tanida, I., Ueno, T., & Kominami, E. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.009 · Cited by 1,461
PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity
Kane, L. A., Lazarou, M., Fogel, A. I., Li, Y., Yamano, K., Sarraf, S. A., Banerjee, S., & Youle, R. J. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402104 · Cited by 1,298
Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
Weerink, M. A. S., Struys, M. M. R. F., Hannivoort, L. N., Barends, C. R. M., Absalom, A. R., & Colin, P. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0507-7 · Cited by 1,208
Bax, Bak and beyond — mitochondrial performance in apoptosis
Peña‐Blanco, A., & García‐Sáez, A. J. (2018) · The FEBS Journal · doi:10.1111/febs.14186 · Cited by 930
Li, Y., Cao, Y., Xiao, J., Shang, J., Tan, Q., Ping, F., Huang, W., Wu, F., Zhang, H., & Zhang, X. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0528-x · Cited by 514
Self-citationZhou, M., Xu, W., Wang, J., Yan, J., Shi, Y., Zhang, C., Ge, W., Wu, J., Du, P., & Chen, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.035 · Cited by 357
Cited by
Potential therapeutic effects of milk-derived exosomes on intestinal diseases
Cui, Z., Amevor, F. K., Zhao, X., Mou, C., Pang, J., Peng, X., Liu, A., Lan, X., & Liu, L. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02176-8 · Cited by 90
Zhang, F.-L., Chen, X., Wang, Y.-F., Hu, Z., Zhang, W., Zhou, B., Ci, P.-F., & Liu, K. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04109-3 · Cited by 87
The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases
He, R., Liu, B., Geng, B., Li, N., & Geng, Q. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01399-w · Cited by 75
Targeting cell death pathways in intestinal ischemia-reperfusion injury: a comprehensive review
Wang, F., Huang, H., Wei, X., Tan, P., Wang, Z., & Hu, Z. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01891-x · Cited by 66
Chu, C., Wang, X., Chen, F., Yang, C., Shi, L., Xu, W., Wang, K., Liu, B., Wang, C., Sun, D., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13538 · Cited by 51
Metadata
- Authors
- Zhang, Q., Liu, X.-M., Hu, Q., Liu, Z.-R., Liu, Z.-Y., Zhang, H.-G., Huang, Y.-L., Chen, Q.-H., Wang, W.-X., & Zhang, X.-K.
- Affiliations
- First Affiliated Hospital of Nanchang University (CN)
- ORCID
- Venue
- Journal of Translational Medicine
- Published
- 2021-11-12
- Volume
- 19
- Issue
- 1
- Pages
- 463-463
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC8588684
- OpenAlex
- W3211551958
- Cited by
- 52
- References
- 68
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 15 · 2023: 15 · 2022: 3
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (No. 81660096)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- dexmedetomidine, intestinal ischemia-reperfusion injury, enteric glial cells, SIRT3, PINK1, HDAC3, p53, mitophagy, apoptosis, perioperative analgesia, mitochondrial damage
- MeSH terms
- Animals, Ischemia, Mitochondria, Neuroglia, Protein Kinases, Reperfusion Injury, Tumor Suppressor Protein p53, Apoptosis, Dexmedetomidine, Rats, Sirtuin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway. https://app.cochat.ai/papers/10.1186/s12967-021-03027-6
- The paper
- Zhang, Q., Liu, X.-M., Hu, Q., Liu, Z.-R., Liu, Z.-Y., Zhang, H.-G., Huang, Y.-L., Chen, Q.-H., Wang, W.-X., & Zhang, X.-K. (2021). Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway. Journal of Translational Medicine. https://doi.org/10.1186/s12967-021-03027-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.